Copay assistance programs exist to help patients afford the high costs of essential medications. For people living with HIV and hepatitis B, lifelong daily treatment is required. For hepatitis C, a curative treatment is available but often comes with a high upfront cost. Without assistance that counts toward out-of-pocket limits, patients in high-deductible or high-cost-sharing plans may be forced to go without treatment. Allowing maximizer programs to flourish, particularly under the false premise that they benefit patients, only reinforces barriers to treatment.
Letter to Michigan Senate supporting bill to ensure copay assistance counts for patients
By passing SB 914, Michigan will join 26 other states, the District of Columbia, and Puerto Rico in protecting consumers purchasing insurance on the private market. This legislation ensures that copay assistance counts toward cost-sharing obligations, preventing patients from facing insurmountable financial barriers to their medications.
Letter to Louisiana Senate Health Committee Opposing Copay Maximizers
While we share your commitment to addressing the high cost of prescription drugs, we strongly oppose HB 1236, legislation that would explicitly authorize the use of copay maximizer programs in Louisiana’s health insurance market.
ACA complaint filed with Pennsylvania Insurance Commissioner on Highmark Marketplace Plans
We are writing to submit a formal complaint regarding plans offered on the Pennsylvania Marketplace by Highmark Inc. Our formulary review has found that Highmark plans offered in the 2026 plan year appear to violate federal Essential Health Benefits (EHB), discrimination, and preventive health coverage requirements in the following ways: (1) use of a copay maximizer; (2) adverse tiering; and (3) non-compliant coverage of preventive health, specifically of HIV pre-exposure prophylaxis (PrEP).
ACA complaint filed with West Virginia Insurance Commissioner on Highmark Marketplace Plans
We are writing to submit a formal complaint regarding plans offered on the West Virginia Marketplace by Highmark Blue Cross Blue Shield West Virginia. Our formulary review has found that Highmark plans offered in the 2026 plan year appear to violate federal Essential Health Benefits (EHB), discrimination, and preventive health coverage requirements in the following ways: (1) use of a copay maximizer; (2) adverse tiering; and (3) non-compliant coverage of preventive health, specifically of HIV pre-exposure prophylaxis (PrEP).